Should I Buy OGEN? OGEN 2026 Analysis

Should You Buy Oragenics Inc (OGEN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.820

1 Day change

-1.79%

52 Week Range

18.900

Analysis Updated At

2026/01/26

Oragenics Inc (OGEN) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows weak financial performance, insider selling, and no strong positive catalysts. Additionally, the technical indicators and trading signals do not support a buy decision.

Technical Analysis

The MACD is slightly positive but contracting, indicating weakening momentum. The RSI is neutral at 35.995, and the stock is trading below key support levels (S1: 0.826, S2: 0.772), suggesting bearish sentiment. Moving averages are converging, showing no clear trend.

Options Data

Positive Catalysts

NULL identified.

Neutral/Negative Catalysts

Significant insider selling, weak financial performance, and a declining stock price in regular and post-market trading.

Financial Performance

In Q3 2025, revenue remained at $0 with no growth. Net income improved by 24.51% YoY but remains negative at -$3,066,589. EPS dropped significantly by -82.69% YoY to -1.96, indicating worsening profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available.

Analyst Rating

Wall Street analysts forecast OGEN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OGEN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold